AI Score
Brand Score | 17 |
Employment Score | 69 |
User Growth Score | 42 |
Fundamental Score | 25 |
What is the target price for vTv Therapeutics?
On October 12, an AI target price of Premium - Sign up was allocated to vTv Therapeutics (VTVT). This projected target price was predicated on several factors, including an encouraging high employee satisfaction, and an encouraging high business outlook across the company's employees.
Is VTVT a Buy, Sell or Hold?
Based on Alternative Data, vTv Therapeutics is a hold.
Should I buy VTVT stock?
Alternative data suggests that it's recommended to approach vTv Therapeutics (VTVT) with caution. While there are positive indicators, the overall assessment suggests a hold based on Alternative Data analysis. However, this information should not be considered financial advice.
What Is the VTVT Stock Forecast for 2025?
With an AI score of 54, the VTVT stock forecast suggests stability.
What is the VTVT price prediction for 2025?
To predict the price for VTVT in 2025, we can extrapolate the AI price target. This approach projects VTVT's price to reach $14.
What is the VTVT price prediction for 2030?
To predict the price for VTVT in 2030, we can again extrapolate the AI price target. This approach projects VTVT's price to reach $20.1.
How do we predict the price for VTVT?
When predicting the price for VTVT, our approach incorporates multiple scores assessing different aspects of the company. The Brand score measures growth and engagement across social media channels, indicating audience reach. The Employee score evaluates workforce health, considering job postings, business outlook, and employee ratings. The Customer score examines engagement on websites, app downloads, and sentiment in stock forums. Lastly, the Fundamental score analyzes financial statements and analyst ratings. By evaluating this data, we gain a holistic view of the company's performance, enabling more informed price predictions.
Will VTVT go up tomorrow?
Based on technical analysis of how the price has moved over the last 6 months is hard to tell since there has been no significant change in the price today to base a prediction on.
Note that this is a simplistic analysis and should be used with caution, as prices are influenced by a myriad of factors.
Similar companies View All
Company | Target Price | |
---|---|---|
Johnson & JohnsonJNJ |
Sign up | |
Eli Lilly and CompanyLLY |
Sign up | |
PfizerPFE |
Sign up | |
AstrazenecaAZN |
Sign up | |
AbbVieABBV |
Sign up |